Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.05
0.03 (2.94%)
At close: Aug 15, 2025, 3:48 PM

Coherus BioSciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
125.99M 102.89M 63.55M 417.19M
Short-Term Investments
n/a 14.86M 128.13M n/a
Long-Term Investments
263K 452K 440K 440K
Other Long-Term Assets
50.2M 70.82M 49.47M 34.49M
Receivables
122.33M 260.52M 109.96M 123.02M
Inventory
70.09M 62.6M 115.05M 93.25M
Other Current Assets
11.53M 11.1M -53.34M -55.61M
Total Current Assets
341.58M 475.63M 381.23M 602.32M
Property-Plant & Equipment
2.84M 11.03M 8.75M 7.81M
Goodwill & Intangibles
53.65M 71.67M 5.93M 3.56M
Total Long-Term Assets
106.95M 153.97M 64.15M 45.87M
Total Assets
448.53M 629.6M 480.85M 679.33M
Account Payables
28.46M 35.22M 11.53M 16.16M
Deferred Revenue
n/a n/a n/a -86.3M
Short-Term Debt
2.84M 2.15M 4.32M 3.49M
Other Current Liabilities
22.95M 1.16M -4.32M 82.81M
Total Current Liabilities
282.98M 331.77M 138.69M 165.33M
Long-Term Debt
264.93M 473.37M 471.06M 408.28M
Other Long-Term Liabilities
28.23M 11.46M 3.47M 750K
Total Long-Term Liabilities
297.54M 491.26M 479.57M 416.28M
Total Liabilities
580.52M 823.03M 618.26M 581.61M
Total Debt
269.9M 480.84M 480.42M 419.02M
Common Stock
12K 11K 8K 7K
Retained Earnings
-1.55B -1.58B -1.34B -1.05B
Comprehensive Income
-275K -248K -249K -270K
Shareholders Equity
-131.99M -193.43M -137.42M 97.73M
Total Investments
263K 14.86M 128.13M 440K